Quarterly Results- overall
Annual Results- Scale
Annual Results- Liquidity
Annual Results- Profitability/Return
Annual Results- Valuation
External Ecosystem
Sector
Major Subsidiaries/Associates
Key Clients
Products
Products
Product details
Operations
Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
|
20% Upper Circuit: Pharma Stock Skyrockets After Reporting 109% YoY Increase in Net Profit
Read More
|
|
Most Active Stocks Today: Sagility, Vodafone Idea
Read More
|
|
Stock Market Gainers and Losers Today: Trent, Infosys
Read More
|
|
Suzlon Sinks 8%, Sagility Down 5%; Vedanta Power Jumps 13%
Read More
|
|
Volume Gainers Today, 30 October 2026 at 11:45 AM IST: Borosil, Quick Heal and Bharat Parenterals Lead
Read More
|
|
Welspun Corp Q2 Net Profit Jumps 12% to Rs 495 Cr
Read More
|
|
Bharat Parenterals Q2 Results FY27: Revenue Up 110.89% to Rs 136.28 Cr, PAT Rs 11.82 Cr
Read More
|
|
Bharat Parenterals Q2FY27 Results: Net profit turns positive at ?11.8 crore
Read More
|
|
Bharat Parenterals Ltd. Estimates – BSE:BPLPHARMA
Read More
|
|
Bharat Parenterals revises EGM voting results to correct categorization
Read More
|
|
Bharat Parenterals schedules EGM on Oct 23 to approve ?139 crore preferential issue
Read More
|
|
Bharat Parenterals shines as its arm commences commercial supply to United States
Read More
|
|
Bharat Parenterals ?? ??????? Innoxel ?? ?????? ?????? ???? ????? ???? ?????? ?? ?????
Read More
|
|
Bharat Parenterals Innoxel US Pharmaceutical Supply Explained
Read More
|
|
Bharat Parenterals Subsidiary Innoxel Starts U.S. Commercial Sales With October 20 Launch
Read More
|
|
Innoxel Lifesciences commences U.S. commercial supply with launch of its first CMO product
Read More
|
|
Bharat Parenterals issues corrigendum on preferential issue disclosures
Read More
|